======= PCGF6 ======= == Gene Information == * **Official Symbol**: PCGF6 * **Official Name**: polycomb group ring finger 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84108|84108]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BYE7|Q9BYE7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PCGF6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PCGF6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607816|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional repressor (PubMed:12167161). May modulate the levels of histone H3K4Me3 by activating KDM5D histone demethylase (PubMed:17320162). Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:12167161). Within the PRC1-like complex, regulates RNF2 ubiquitin ligase activity (PubMed:26151332). {ECO:0000269|PubMed:12167161, ECO:0000269|PubMed:17320162, ECO:0000269|PubMed:26151332}. |zf-C3HC4| |inactivation of X chromosome by genetic imprinting| |histone H2A-K119 monoubiquitination| |PRC1 complex| |dosage compensation by inactivation of X chromosome| |regulation of gene expression by genetic imprinting| |histone H2A monoubiquitination| |dosage compensation| |genetic imprinting| |histone H2A ubiquitination| |PcG protein complex| |histone monoubiquitination| |negative regulation of G0 to G1 transition| |histone ubiquitination| |regulation of G0 to G1 transition| |protein monoubiquitination| |regulation of gene expression, epigenetic| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |RNA polymerase II regulatory region sequence-specific DNA binding| |negative regulation of cell cycle process| |histone modification| |covalent chromatin modification| |negative regulation of cell cycle| |DNA-binding transcription factor activity| |protein ubiquitination| |chromatin organization| |regulation of cell cycle process| |protein modification by small protein conjugation| |negative regulation of transcription by RNA polymerase II| |protein modification by small protein conjugation or removal| |chromosome organization| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-2.64| |[[:results:exp360|Genistein 15μM R07 exp360]]|-1.71| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|1.7| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.72| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.96| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2.02| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9335 * **Expression level (log2 read counts)**: 4.74 {{:chemogenomics:nalm6 dist.png?nolink |}}